UCK2 upregulation has been reported in several types of cancers including lung cancer [10, 11], breast cancer [12, 13], neuroblastoma [14, 15], colorectal cancer [16], pancreatic cancer [17], and HCC [18–21]. Here, UCK2 is linked to hepatocellular carcinoma.